Dear PES Members, As a dual US and Canadian citizen, I admit that I find these times particularly sad and…
Read MoreMore Articles
Dear Colleagues, With the first month of the academic year behind us, and the frenzy of September quietening down, it is time of take stock of a most unusual summer…
Read More
Prepared by: Vandana Raman, Shilpa Mehta, and Amit Lahoti. Last Updated on: 8/11/20 Liraglutide is a long-acting analog of human glucagon-like peptide (GLP)-1. It was approved by the FDA in…
Read More
Fri 16 October 16, 2020 / 2:00 pm – 4:30 pm PES Leadership Advantage FALL MODULE OFFERING Since our virtual, live delivery of the INFLUENCE module in May was a…
Read More
PES Going Virtual for 2021 We are pleased to announce the dates for the PES 2021 VIRTUAL Annual Meeting! April 30th- May 3rd, 2021 We are excited to think innovatively…
Read More
Prepared by Bhuvana Sunil, MD and Ambika Ashraf, MD Burosumab twza (Crysvita – Ultragenyx pharmaceuticals) is an injectable recombinant IgG1 human monoclonal antibody preparation neutralizing fibroblast growth factor 23 (FGF-23).…
Read More
My name is Iman, and I just started the third year of my pediatric endocrinology fellowship at Baylor College of Medicine/Texas Children’s Hospital. I consider myself a global citizen, as…
Read More
Name: Amanda Barks Year: G5/MS3 (Defending thesis and returning to clinic summer 2020) Program: MD/PhD School: University of Minnesota Medical School What is your most…
Read More
Name: Meredith Hanrahan Year: 3rd Year Medical Student (Class of 2022) Program: M.D. Program School: Geisinger Commonwealth School of Medicine What is your most memorable experience in…
Read More
Prepared by Christine Yu and Amit Lahoti Semglee™ is a new biosimilar insulin with an identical amino-acid sequence to insulin glargine. Semglee™, co-developed by Mylan Inc. and Biocon Ltd., was…
Read More
Prepared by: Seth Marks and Amit Lahoti Updated July 22, 2020 The FreeStyle Libre 2 is the second generation of Abbott Laboratories’ flash glucose monitoring system. It was approved by…
Read More